Serum endocan levels in non-ST segment elevation myocardial infarction patients
Frontiers in Cardiovascular Medicine · 03.06.2026 · 13
DOI: 10.3389/fcvm.2026.1783106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Adem Melekoglu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sisli Hamidiye Etfal Education and Research Hospital, Emergency Medicine, İstanbul, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endothelial dysfunction and inflammation play a key role in the pathophysiology of acute coronary syndrome (ACS). Endocan has emerged as a novel biomarker reflecting endothelial activation.
Objective
To investigate serum endocan levels in patients with non–ST-segment elevation myocardial infarction (NSTEMI) and their association with coronary stenosis severity.
Methods
This prospective observational study included 81 NSTEMI patients undergoing coronary angiography. Patients were classified into clinically significant coronary stenosis and non-significant coronary stenosis groups. Serum endocan levels were measured at admission.
Results
Patients who underwent coronary angiography ( n = 81) were divided into two groups as those with clinically significant coronary stenosis ( n = 40) and non-significant coronary stenosis ( n = 41). Serum endocan levels were significantly higher in the group with clinically significant coronary stenosis ( p < 0.001). Mean age and body mass index (BMI) were higher and statistically significant in the group with clinically significant coronary stenosis ( p = 0.038, p = 0.042). Inflammation parameters C-reactive protein (CRP), White Blood Cell (WBC) and Neutrophil Lymphocyte ratio (NLR) were higher in the group with clinically significant coronary stenosis ( p < 0.001, p = 0.011, p = 0.038). In multivariate logistic regression analysis, endocan ( p < 0.001, 95% CI: 1.010–1.035), BMI ( p = 0.020, 95% CI: 1.070–2.237), and CRP ( p = 0.039, 95% CI: 1.003–1.099) were independently associated with clinically significant coronary stenosis. In Receiver operating curve (ROC) analysis performed to discriminate between patients with and without clinically significant coronary stenosis, the endocan cut-off value was determined as > 393.1 ng/L [ p < 0.001, The Area Under the Curve (AUC) = 0.826, 95% CI = 0.732–0.919, Likelihood Ratio + = 7.65, LR - = 0.28].
Conclusion
Endocan levels are elevated in NSTEMI patients with clinically significant coronary stenosis and may reflect endothelial dysfunction and atherosclerotic burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sisli Hamidiye Etfal Education and Research Hospital, Emergency Medicine, İstanbul, Türkiye.
- Department of Emergency Medicine, Ministry of Health Eskişehir City Hospital, Eskişehir, Turkiye.
- Emergency Department, University of Health Sciences Gulhane Training and Research Hospital, Ankara, Turkiye.
- Department of Biochemistry, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkiye.
- Department of Cardiology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkiye.
Zitieren
APA
Melekoglu, A., Aydin, A. G., Kahveci, U., Ozcan, N., Ceritli, S., Kara, Z. M. Y., Kilci, H., Altinbilek, E., & Ozturk, D. (2026). Serum endocan levels in non-ST segment elevation myocardial infarction patients. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1783106
Vancouver
Melekoglu A, Aydin AG, Kahveci U, Ozcan N, Ceritli S, Kara ZMY, et al. Serum endocan levels in non-ST segment elevation myocardial infarction patients. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1783106
BibTeX
@article{Melekoglu2026,
author = {Melekoglu, Adem and Aydin, Alp Giray and Kahveci, Uğur and Ozcan, Nazmiye and Ceritli, Serkan and Kara, Zeynep Mine Yalcinkaya and Kilci, Hakan and Altinbilek, Ertugrul and Ozturk, Derya},
title = {Serum endocan levels in non-ST segment elevation myocardial infarction patients},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1783106}
}
EUVIMED